Two lawsuits claiming Merck lied about the efficacy of its mumps vaccine won't be going away anytime soon. A federal judge in Pennsylvania refused to dismiss the suits, filed by a pair of whistleblowers and a group of doctors and payers, and now, they're on their way to trial.
Some studies in low-income countries have shown that widespread immunization can cause unexpected positive consequences. A Danish team has now generated evidence that some of these unintended benefits are seen in wealthy countries, too.
GlaxoSmithKline has been listening to parents' concerns about childhood vaccinations. Really listening. In fact, it has used big data analytics to sift through thousands of comments from Internet chat forums to try to get a better grasp of exactly what objections there are and how to best face them.
The vaccine for measles, mumps and rubella (MMR) has proven an effective tool in the past. In 2008, a U.K. study found one dose protects 95% of people against measles, with the follow-up shot immunizing most of the remaining 5%. Now similar data is emerging from Wales.
An Italian health news website seems to have reported that an Italian court has ruled that an MMR vaccine caused autism in a child.